Precise™ Oncology Solutions is a comprehensive offering designed to help oncologists determine effective and personalized treatment plans for individual patients. It provides physicians with streamlined testing that combines germline testing, tumor profiling and companion diagnostic options including evaluation for Homologous Recombination Deficiency (HRD), an important cancer repair pathway. Precise Oncology Solutions includes Myriad’s new Precise™ Tumor Molecular Profile Test. Precise Oncology Solutions is currently available for patients with solid cancer tumors.
Solid Tumor